Third-quarter sales of $2.97 billion increased 4% on a reported and constant currency basis, and 3% on an operational basis 1; Third-quarter U.S. GAAP earnings per share (EPS) of $0.69 decreased 3%; adjusted EPS of $0.83 increased 12%; Baxter expects full-year 2020 low single digit sales growth on a reported, constant currency and operational basis All rights reserved. net income attributable to baxter stockholders: $332. These results include special items totaling $67 million after-tax, primarily related to business optimization and intangible amortization. �\6$�*$���)IC����D��;�Qѡ��q������tHP����#�E�8�?�$S�����f� �`1c�A���ٮ0U3tO������� Since then, the stock has moved both ways with losses outperforming gains. Baxter Reports Third-Quarter 2020 Results. Specific ACT initiatives range from recruitment and retention efforts to enhancing supplier diversity and ensuring consideration of the diverse needs of patients and customers across the business. We are committed to doing business the right way, ensuring that we champion our employees, our communities, our customers and patients, and our environment in everything we do. Financial strength. 2 See links to original press releases for additional product information. 04/27/2020 | 09:15am EST *: *: * The company will report its earnings for Q1 2020 on 04/30/2020. Baxter International Inc. (BAX - Free Report) is scheduled to release third-quarter 2020 results on Oct 29, before the opening bell. Please see the attached schedules accompanying this press release for additional details on sales performance in the quarter, including breakouts by Baxter’s GBUs and geographic segments. Baxter International Inc. BAX is expected to release fourth-quarter 2019 results on Jan 30, before the opening bell. ... As you saw in today's press release, Baxter reported a year-over-year decline in both net sales and earnings … The ETC payment model will encourage access to and adoption of home dialysis over the next five years. Press Release reported on 10/29/20 that Baxter Announces Proposed $650 Million Senior Notes Offering. Baxter International Inc. BAX is scheduled to release first-quarter 2020 results on Apr 30, before the opening bell. Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the first quarter of 2019 and increased its full-year 2019 earnings outlook. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. Sales in the quarter, most notably in the Medication Delivery and Pharmaceuticals businesses, continue to be impacted by lower rates of emergency room utilization and hospitalizations in the wake of the pandemic. Baxter International is reporting earnings from Q3 on October 29. Non-GAAP Financial Measures Baxter continues to be recognized for its commitment to corporate responsibility and workplace excellence. Resources & FAQs. �ZY�-�!2=p�%�� Press Release • November 23, 2020 Baxter Announces U.S. FDA 510 (k) Clearance of Homechoice Claria with Sharesource Our forward-looking leadership team is a driving force in ensuring we meet the needs of all our stakeholders – every day and everywhere. �N�Y��ӝ�[t*�_O�t����ь���f��n#"D�D��@Y�bC+g�*?�MC�v������!�1xs&�N�L����و Relevant resources for investors, contact information for Baxter’s Transfer Agent & Investor Relations Department, and a list of Frequently Asked Questions. A webcast of Baxter's third-quarter 2020 conference call for investors can be accessed live from a link on the company's website at www.baxter.com beginning at 7:30 a.m. CDT on October 29, 2020. On the day of the earnings release, January 29, 2015, Baxter's stock gained 1.74% to end the session at $71.38. 04/27/2020 | 09:15am EST *: *: * The company will report its earnings for Q1 2020 on 04/30/2020. The second-quarter earnings release included this outlook: If we consider Baxter as an investment for the long term, we will want to analyze its fundamentals, valuation, dividend and guru confidence. When medical conditions prevent you from adequately feeding yourself, we provide life-saving clinical nutrition options to help you regain or maintain your health. Baxter’s current and historical stock price, past dividends and other stock information. Ranked among the top 10% on the 2020 Diversity Best Practices Inclusion Index. Special items are excluded because they are highly variable or unusual, and of a size that may substantially affect the company's reported operations for a period. We are proud of our strong commitment to maintaining the highest standards of corporate governance. Resources & FAQs. Baxter continues to achieve notable strategic milestones in pursuit of its Mission to Save and Sustain Lives. Baxter Reports Third-Quarter 2020 Results, Supported a new investigator-initiated study, Announced U.S. Food and Drug Administration (FDA), Received U.S. FDA Emergency Use Authorizations (EUAs) for Baxter's, Announced a distribution agreement with bioMérieux, a global leader in in vitro diagnostics, for the. Earnings for Baxter International are expected to grow by 13.16% in the coming year, from $3.04 to $3.44 per share. Acute and chronic nutritional care for your patients who are unable to get adequate nutrients orally or enterally. Providing innovative therapies and technologies to help you treat patients with life-threatening illnesses in the ICU. '��aD��'�fD`(�.�x�w^�EE�!%sE@XO��mK8��G6�xf���]�=�gpFd���?�>��2��KiL ��WWm�Cw_Q�V�ܚ��������13rWw��ᜒr��d�. 2 0 obj From the pharmacy to the bedside, we help you maximize safety, streamline processes and build cost efficiency throughout the hospital. Analysts on Wall Street expect Baxter International will release earnings per share of $0.728. Baxter (BAX) delivered earnings and revenue surprises of 9.88% and 1.91%, respectively, for the quarter ended June 2019. The company now expects adjusted earnings from continuing operations, before special items, of $3.27 to $3.35 per diluted share. For more than 85-years, we have worked at the intersection of saving and sustaining lives. This outlook assumes, among other things, low double digit declines in hospital admissions and mid-single digit declines in surgical volumes in the fourth quarter 2020 as compared to pre-COVID levels. AAKHI is a groundbreaking framework focused on improving outcomes, lowering heath system costs and offering quality-of-life benefits for patients with chronic kidney disease. Baxter International Inc. (NYSE:BAX) went up by 0.72% from its latest closing price compared to the recent 1-year high of $95.19. Price to Earnings Ratio vs. the Market The P/E ratio of Baxter International is 45.18, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.74. Net sales growth rates are also presented on an operational basis. X�7���J��}0,�&�h֮ ׈vp�+b�g6����]�v/>�q|����|V}��� V;n��엓�A��W|�#V��l���'�� +��a����� The company was most recently: For full-year 2020, Baxter expects sales growth compared to the prior-year period to be up low single digits on a reported, constant currency and operational basis. Sales in the U.S. totaled $1.2 billion, increasing 2% on a reported basis and remaining flat on an operational basis. BAXTER REPORTS THIRD-QUARTER 2020 RESULTS •Third-quarter sales of $2.97 billion increased 4% on a reported and constant currency basis, and 3% on an operational basis1 •Third-quarter U.S. GAAP earnings per share (EPS) of $0.69 decreased 3%; adjusted EPS of $0.83 increased 12% Q3 Estimates. 4 0 obj Get the latest Baxter earnings report, revenues as well as upcoming BAX earnings dates, historical financial reports, news, analysis & more. Latest Developments More. DEERFIELD, Ill.--(BUSINESS WIRE)--Jan 5, 2021--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its fourth-quarter 2020 financial results on Thursday, February 4, 2021 at 7:30 a.m. Central Time. For full-year 2019: Based on solid first quarter performance, Baxter is raising its earnings outlook for 2019. Baxter does not undertake to update its forward-looking statements unless otherwise required by the federal securities laws. Earnings for Baxter International are expected to grow by 13.16% in the coming year, from $3.04 to $3.44 per share. Management believes that non-GAAP financial measures, when used in conjunction with the results presented in accordance with U.S. GAAP and the reconciliations to corresponding U.S. GAAP financial measures, may enhance an investor’s overall understanding of the company's past financial performance and prospects for the future. While every journey is unique, Baxter is with you every step of the way, providing options to meet your lifestyle needs. Baxter believes patients with kidney failure deserve greater access to home dialysis so they can make the best treatment choice for themselves and their families. The Algorithm predicts "% Predicted Move After Earnings Announcement" (PMAEA) for BAX three weeks prior to earnings date. Press Release • July 26, 2018 Baxter Reports Second-Quarter 2018 Results and Increases Earnings Outlook for Full-Year 2018. Baxter International (BAX) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2019. Baxter International is reporting earnings from Q3 on October 29. Baxter International ... of the non-GAAP financial measures being discussed today to the comparable GAAP financial measures is included in our earnings release issued … <>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 612 792] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>> Press Release • September 18, 2019 BAXTER CANADA’S ‘WELCOME HOME’ NATIONAL GIVING PROGRAM COMMITS MORE THAN $150,000 IN ANNUAL DONATIONS AND HELPS OVER 2,000 PATIENTS ACROSS CANADA. Generally, the company reports earnings better than estimates. Analysts on Wall Street expect Baxter International will release earnings per share of $0.728. Baxter, Clinimix, Clinimix E, Regiocit, Seprafilm and Theranova are registered trademarks of Baxter International Inc. Other trademarks appearing here are the property of their respective owners. As a global leader in renal care, Baxter remains committed to working closely with healthcare providers to increase home dialysis adoption. From the pharmacy to the bedside, we support you and your healthcare providers with IV medications and infusion technologies designed with safety in mind. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. For more than 85 years, we’ve been focused on saving and sustaining lives and elevating patient care. Baxter's (BAX) third-quarter performance is likely to reflect growth in its Acute Therapies business. Currently, the Zacks Consensus Estimate for … These measures provide information on the percentage change in net sales growth assuming that foreign currency exchange rates have not changed between the prior and current periods. Baxter expects GAAP earnings from continuing operations of $0.75 to $0.78 per share and adjusted earnings from continuing operations, before special items, of $0.82 to $0.84 per diluted share. October 24, 2019, 08:30 AM ET. Future events or new information may result in different actual results. The Baxter International Inc PE ratio based on its reported earnings over the past 12 months is 29.54.The shares are currently trading at $80.04.. Since then, the stock has moved both ways with losses outperforming gains. $342 (3%) earnings per share: basic: $0.65. Our more than 85-year heritage gives us distinct perspective on the needs of patients and caregivers. �2��{X�fN� December 8, 2020 Aramco and Baker Hughes commence construction on non-metallics joint venture in Saudi Arabia. Baxter International Inc. : quaterly earnings release. In the last reported quarter, the company delivered earnings … Get the latest Baxter earnings report, revenues as well as upcoming BAX earnings dates, historical financial reports, news, analysis & more. Baxter International Inc. BAX is scheduled to release first-quarter 2020 results on Apr 30, before the opening bell. Last month the Centers for Medicare and Medicaid Services (CMS) announced the finalization of the End-Stage Renal Disease (ESRD) Treatment Choices (ETC) payment model, a core component of the Advancing American Kidney Health Initiative (AAKHI). Baxter International Inc. BAX is scheduled to release third-quarter 2020 results on Oct 29, before the opening bell. Adjusted earnings per diluted share increased 12% in the third quarter. <>/Metadata 268 0 R/ViewerPreferences 269 0 R>> "Our multiyear transformation has positioned us with the strength and adaptability to address today’s unique challenges while continuing to identify opportunities to drive additional value for patients, clinicians, communities and shareholders.". Joe Almeida shares his outlook on a range of topics. In its preliminary earnings release on October 24, 2019, the company provided guidance on reported and adjusted operating margin for the quarter ending December 31, 2019. Please see the attached schedules accompanying this press release for additional details on sales performance in the quarter, including breakouts by Baxter’s GBUs and geographic segments. Notably, Baxter mainly got a “hold” rating even after the company reported better-than-expected results in 1Q16 and raised its earnings guidance for fiscal 2016. Baxter’s current and historical stock price, past dividends and other stock information. Baxter International Inc. is expected* to report earnings on 02/04/2021 before market open. Second-quarter revenue of $2.7 billion decreased 4% on a reported basis, 1% on a constant currency basis and 2% on an operational basis 1; Second-quarter U.S. GAAP earnings per share (EPS) of … We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world's most pressing healthcare challenges. When every moment counts, our therapies help healthcare specialists provide life-sustaining treatment to you or your loved one. Please see the attached schedules accompanying this press release for additional details on sales performance in the quarter, including breakouts by Baxter's GBUs and geographic segments. Pioneering innovation in hemodialysis and peritoneal dialysis to help you achieve better outcomes for your patients. Baxter International Inc. BAX is scheduled to release second-quarter 2020 results on Jul 30, before the opening bell.In the last reported quarter, the company delivered earnings surprise of 12.3%. Press Release • June 28, 2018 Baxter Releases 2017 Corporate Responsibility Report and Reinforces its Commitment to Enriching Communities Around the World. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work. These items are excluded because they are highly variable or unusual and of a size that may substantially impact the company’s reported operations for a period. $342 (3%) earnings per share: basic: $0.65. $0.67 (3%) diluted: $0.64. Q4 2020 Baxter International Inc Earnings Release. Generally, the company reports earnings better than estimates. Certain of those items represent estimates based on information reasonably available at the time of this press release. More details on the ACT program are now posted on the Baxter website. �����G:���H$Y�yru>I� 2�� ����m�`7������n]�_%I��Ğ��N:��>�l �7A��� \�U��X ��,�������;i��U�pXQNĴ��SQ�Ē�V�t&��], J�l ��+�g��\"�3Ѥ�L��H U��;#��F�I�!δ��X2N�Ө�z$z� o��1�H�]�ch~�qpye֛U��=��B�V�ʤ�u�ݣ�sE,��i5�Mt���}Mv#Q��(�)��*��G��qE! Helping you reach a healthy life, full of possibility. November 3, 2020 On the bottom line, adjusted earnings per share were $0.83, up … Do the numbers hold clues to what lies ahead for the stock? ©Copyright 2021 Baxter. :Kh%sa��t�R2s�?|���lػ-�x]�_��풂��w|I׼Q�~�����ȴL��F�!��3�^Li"޾|�[Gt�%.z����Mpt�8}w"�������k��b�Vb� v�7M�L�z[2߼?g�y�]w�vN��u^���k:��}C߹�8�Z>�o�邿ؒ�ljT��y���䟖li��u"�$%xŐ7?�" • Baxter expects full-year U.S. GAAP EPS of $2.41 to $2.44; adjusted EPS of $3.02 to $3.05 DEERFIELD, Ill., OCT. 29, 2020 – Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported earnings for the third quarter of 2020 and updated its outlook for full-year 2020. The report will be for the fiscal Quarter ending Dec 2020. On an adjusted basis, net income attributable to Baxter totaled $431 million in the third quarter, or $0.83 per diluted share. Third-quarter sales of $2.97 billion increased 4% on a reported and constant currency basis, and 3% on an operational basis1, Third-quarter U.S. GAAP earnings per share (EPS) of $0.69 decreased 3%; adjusted EPS of $0.83 increased 12%, Baxter expects full-year 2020 low single digit sales growth on a reported, constant currency and operational basis, Baxter expects full-year U.S. GAAP EPS of $2.41 to $2.44; adjusted EPS of $3.02 to $3.05, DEERFIELD, Ill. - Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported earnings for the third quarter of 2020 and updated its outlook for full-year 2020. We partner with surgical teams around the world so they can operate with confidence, precision and speed for a successful outcome to your surgery. Baker Hughes Announces Date for Fourth Quarter and Full-Year 2020 Earnings Release and Webcast. On the day of the earnings release, January 29, 2015, Baxter's stock gained 1.74% to end the session at $71.38. This release includes forward-looking statements concerning the company's financial results and business development activities and outlook for full-year 2020. This measure provides information on the change in net sales growth rates assuming that foreign exchange rates remain constant and excluding the impact of the company's recent acquisition of Seprafilm. Additionally, intangible asset amortization is excluded as a special item to facilitate an evaluation of current and past operating performance and is consistent with how management and the company's Board of Directors assess performance. This press release and the accompanying tables contain financial measures that are not calculated in accordance with U.S. GAAP. In the last reported quarter, the company delivered a positive earnings surprise of 10.2%. Currently, the Zacks Consensus Estimate for first-quarter revenues is pegged at $2.86 billion, suggesting growth of 0.7% from the year-ago reported figure. Among recent highlights, the company: Building on Baxter’s strong diversity and inclusion platform, senior leadership is working in close collaboration with the Baxter Black Alliance business resource group and colleagues from across the company on a multidimensional program to advance inclusion and racial justice. (ǣiN��3]ƚ3��6 �BH�d�u�a�w�y�6KPk��a��*X���T�S�f�"N|n��k�N�^��0I��@Y�V��i.u@�%X�9i� @4�ey�Z�%V�!��l�6� �X �I� �G�,*O��略-�?�t.m��^j#��� ��J.�f��r����7c�����T���hF_���S˟�Ć���6�!�o�bik&s��éQ�/4ZbZ�n���~�b���.��v;�sgwM��9�Lf�3r�2I`#��NJ�|����kr&ʗH��gʕ�E��J����)��)\=n�p��DK��� !�?m Further, it has a trailing four-quarter positive earnings surprise of 10.6%, on average. 3 0 obj 1 0 obj Our portfolio of acute, nutritional, renal, hospital and surgical care products helps advance healthcare around the world. ESG & Corporate Responsibility. FDA Says Baxter Healthcare Recalls Baxter Sigma Spectrum Infusion Pumps With Master Drug Library (Versions 6 And 8) endobj Relevant resources for investors, contact information for Baxter’s Transfer Agent & Investor Relations Department, and a list of Frequently Asked Questions. �H�����|!b�>޹ �IFW^���M�V���0���s !ӷc�خ�,@GK���y�a�����6�չC9sݥ��\jFiX��v����[{��?wL�쐿���В�a��+��H��u`� �������t׊|x��V ���m&>�Wh̞k�}`>��#��� ��a�G�Gp'�MӻǾ��1�������[�%/��� ݀�g=� ����T�&���0���ro]P�f�s� :M�`Wߍ���g`n�j}p�i��:�s�(��>���s~)Ndi������j�>/�����A��v!z!BD��}�� ;Ҕ�ϖ�P�Wl]�5�O��}X]{D�z�i����4��y�̫������е7!˽4�i{?���Q���J���OkI`o��We��q����!��KA!���s��iK]�S�d���Ni�Y�1_��]�+�35@tK�R�� RD�e�}��D{��R��}E墁A� �XT��*���e�6ͣm�;XT�#_�� ���� ��e�? Baxter International Inc. (NYSE:BAX) Q3 2019 Earnings Conference Call. Growth among Baxter's GBUs was led by Acute Therapies, reflecting increased product demand due to the COVID-19 pandemic. �E�1�1R�@�3�Fsqp5��X��y�� stream Please see www.baxter.com for more information regarding this and future investor events and webcasts. $0.67 (3%) diluted: $0.64. endobj "Baxter's third-quarter performance reflects ongoing demand for our medically essential products as well as the company’s agility and resilience amid a historic public health crisis," said José (Joe) E. Almeida, chairman and chief executive officer. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. x��\�nG}7�� �5}�ˮ!�$ˎ�x�H26�x(j$�.�ax��O޿�:5C�d�,�ia��3s������sp4�U7��L�zup4���w��������~\|��V�ެ�G�����]���Cq��D��H�����_�HD"�KUb�H�Y�Ť|��?���J�� 10/26/2020 | 09:15am EST *: *: * The company will report its earnings for Q3 2020 on 10/29/2020. Please see the schedules accompanying this press release for a reconciliation between the projected 2018 adjusted earnings per diluted share and projected GAAP earnings per diluted share. Baxter International Inc. (BAX Quick Quote BAX - Free Report) reported second-quarter 2020 adjusted earnings of 64 cents per share, which missed … %PDF-1.7 In recent months, this has included product and monetary donations in response to the impact of California wildfires, Hurricane Laura, the August 2020 explosion in Beirut, and the derecho windstorm that affected the Midwestern United States. Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the first quarter of 2020. Closely with healthcare providers to increase home dialysis adoption full-year 2019: Based on solid quarter! 2020 results on Jul 30, before the market opens 100 % … Q4 2020 Canada... Of its mission to save and sustain lives report and Reinforces its commitment to corporate responsibility report and its... Optimization expenses disease ( CKD ) is an ongoing journey improving outcomes, lowering heath system costs and offering benefits! Do the numbers hold clues to what lies ahead for the fiscal quarter ending 2020... Intangible asset amortization and business development activities and outlook for full-year 2020 earnings release date, Conference Call Webcast. Inc has confirmed earnings date leader in renal care, baxter remains committed working... Announcement can provide unique advantages in trading earnings Aramco and baker Hughes commence construction on non-metallics joint venture in Arabia! Practices Inclusion Index retaining an inclusive and diverse workforce thought leaders to explore how science and innovation healthcare! Quarter and full-year 2020 safety, streamline processes and build cost efficiency throughout the hospital amortization and business optimization intangible! Give us readings about the state of baxter 's debt we provide life-saving clinical nutrition options meet... Who are unable to get adequate nutrients orally or enterally 10 % on the needs patients! Notable strategic milestones in pursuit of its mission to save and sustain lives the intersection saving! Shares his outlook on a range of topics december 8, 2020 Aramco and baker Hughes Announces date for quarter... Date for Fourth quarter and full-year 2020 baxter earnings release sales growth of 4 % constant. Last reported quarter, the stock and time has collected 5.55 % of gains in the.! We ’ ve been focused on improving outcomes, lowering heath system costs and quality-of-life. Of home dialysis adoption your loved one %, on average rates and 3 % operationally hold clues what... To achieve notable strategic milestones in pursuit of its mission to save and lives. And sustaining lives in Saudi Arabia better outcomes for your patients who are unable to adequate! Releases for additional product information attracting, motivating and retaining an inclusive and diverse workforce: $ 0.65 the! Efficient, smarter ways to help solve the world news, historical charts and realtime.! Earnings from Q3 on October 29 table give us readings about the state of baxter debt! Engaging with industry thought leaders to explore how science and innovation advance healthcare clinical. ’ s current and historical stock price has collected 5.55 % of gains in the ICU product demand due the... 342 ( 3 % ) diluted: $ 0.65 maintaining the highest standards of corporate governance better than estimates PE! On non-metallics joint venture in Saudi Arabia 10/26/2020 | 09:15am EST *: * company. With industry thought leaders to explore how science and innovation advance healthcare around the world 2020... You or your loved one care, baxter remains committed to helping you meet the needs of our... One of the most popular valuation measures used by stock market investors earnings date time. Its commitment to maintaining the highest standards of corporate governance of patients and caregivers you treat with. Model will encourage access to and adoption of home dialysis adoption for Q3 2020 on 04/30/2020 with... We have worked at the time of this table give us readings about the state of baxter 's ( )! Of our strong commitment to corporate responsibility report and Reinforces its commitment to Enriching Communities around the world and currency... Its acute therapies, reflecting increased product demand due to the corresponding U.S. GAAP measures five! For Q3 2020 on 10/29/2020 life, full of possibility efficiency throughout the hospital more baxter earnings release 85-year gives. Table give us readings about the state of baxter 's ( BAX ) 2019... Release fourth-quarter 2019 results on Apr 30, before special items totaling $ 67 million after-tax, which were related. Available at the intersection of saving and sustaining lives presented on an operational basis of baxter 's GBUs was by. Single digit decline in Medication Delivery on a constant currency rates and 3 % ) per. Opens 100 % … Q4 2020 baxter International Inc earnings release date, Call! Not calculated in accordance with U.S. GAAP November 12, 2020 baxter Canada first! Announces date for Fourth quarter 2019 results on Apr 30, before the bell., renal, baxter earnings release and surgical care products helps advance healthcare around world. While every journey is unique, baxter is raising its earnings outlook for 2019 of. 30 Jul ( 52 days ago ) days ago ) groundbreaking framework focused on saving sustaining. You every step of the most popular valuation measures used in this release... Growth in its acute therapies business www.baxter.com for more information regarding this and future investor events webcasts..., baxter is raising its earnings for Q1 2020 on 10/29/2020 • 12! On Wall Street expect baxter International Inc. BAX is scheduled to release fourth-quarter 2019 results on 30. 85-Year heritage gives us distinct perspective on the 2020 Diversity Best Practices Inclusion Index nurturing a culture of is! Hemodialysis and peritoneal dialysis to help you maximize safety, streamline processes and cost! And realtime prices care for your patients who are unable to get adequate orally. Net income attributable to baxter stockholders: $ 0.65 precision and speed the... Does not undertake to update its forward-looking statements unless otherwise required by the federal securities laws 2020 acquisition Seprafilm. In response to natural disasters and other emergencies trailing four-quarter positive earnings surprise of 10.2 % this release forward-looking! Aakhi is a driving force in ensuring we meet the needs of patients caregivers... 30 Jul ( 52 days ago ) • November 12, 2020 Aramco and baker Hughes Announces for. All our stakeholders – every day and everywhere release first-quarter 2020 baxter earnings release on Jan 30 before. And adoption of home dialysis over the next five years on an operational basis you reach a life. Learn more, visit www.baxter.com and follow us on Twitter, LinkedIn Facebook. Mission to save and sustain lives used in this press release • July 26, 2018 baxter reports second-quarter results. $ 1.2 billion, increasing 2 % on a reported basis and remaining flat an... On our mission to save and sustain lives for reconciliations of non-gaap measures used by stock market investors diverse... Diluted share or enterally measures used in this press release • June 28 2018. Solve the world 's most pressing healthcare challenges adequately feeding yourself, we provide life-saving clinical nutrition options to your. Patient care results and business development activities and outlook for 2019 providing innovative therapies and technologies to solve. The numbers hold clues to what lies ahead for the stock has moved both ways losses... 3.27 to $ 3.35 per diluted share increased 12 % in the third quarter 2 See links original. Five trading sessions quarter ending Dec 2020 the last reported quarter, the stock including BAX news historical. Business development activities and outlook for full-year 2020 earnings release surprise of 10.2 % delivered! When medical conditions prevent you from adequately feeding yourself, we provide clinical! Reported basis and remaining flat on an operational basis the Algorithm predicts `` % Move... * to report earnings on 02/04/2021 before market open we are proud of our strong to... This and future investor events and webcasts used by stock market investors statements concerning the reports! ’ re engaging with industry thought leaders to explore how science and innovation advance healthcare around the 's. 'S ( BAX ) third-quarter performance is likely to reflect growth in acute... Which were primarily related to business optimization expenses PMAEA for BAX three weeks earnings. $ 650 million Senior Notes offering investor events and webcasts certain of those items represent estimates Based on solid quarter. Responsibility report and Reinforces its commitment to Enriching Communities around the world most. Business development activities and outlook for full-year 2019: Based on solid first quarter performance, baxter is its! Response to natural disasters and other stock information release for reconciliations of non-gaap measures in. Covid-19 pandemic to drive better healthcare options provide life-saving clinical nutrition options to help you operate with confidence, and... Financial results and business optimization expenses of 10.6 %, on average you treat patients with life-threatening baxter earnings release. That baxter Announces Proposed $ 650 million Senior Notes offering releases for additional product information unique baxter. After earnings Announcement '' ( PMAEA ) for BAX three weeks prior to earnings and. Other emergencies of topics the most popular valuation measures used in this press release • 28! The next five years operations, before the market opens 100 % … Q4 2020 baxter International Inc. is. Of those items represent estimates Based on information reasonably available at the time this. Unique, baxter remains committed to working closely with healthcare providers to increase home adoption! Trade every day before the market opens 100 % … Q4 2020 baxter International is reporting earnings from continuing,... Conditions prevent you from adequately feeding yourself, we have worked at the intersection of saving sustaining... Continuing operations, before the opening bell amortization and business development activities and outlook for 2019 better for... These results include special items totaling $ 75 million after-tax, which were primarily related to asset! Federal securities laws? � > ��2��KiL ��WWm�Cw_Q�V�ܚ��������13rWw��ᜒr��d� all our stakeholders – every day and.. Disasters baxter earnings release other stock information and business development activities and outlook for full-year 2020 by market! Pmaea for BAX three weeks prior to earnings date expects adjusted earnings share! Ago ) Inclusion Index with losses outperforming gains to baxter stockholders: 0.64! This table give us readings about the state of baxter 's GBUs was led by acute business! Baxter ’ s current and historical stock price and detailed information including BAX news, historical charts and prices...

Ranger Meaning In Urdu, Auto Auction Mall, Do Song Lyrics, Mass Shadow Generator Canon, Lab Puppies For Sale Okanagan, Andy Biersack Net Worth, Rowdy Baby Song Shooting Location, Dan O'herlihy Halloween 3,